Hester Biosciences Limited

Web: hester.in NSE: HESTERBIO BSE: 524669 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

2176 91(-4%)

Volume

7k as on 23, Jun

Open

2,410

High

2,419

Low

2,365

2,267

VWAP

2,136

52 Week High

2,684

52 Week Low

1,239

Viand Research Rating

Quality Score

75/100

Growth Score

59/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,851

No. of Shares

0.85

P/E

69.78

P/B

6.79

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

9.73

ROCE

Profit Growth

Listing Date

13-Mar-15

Rank/Sector Rank

#1283/#107

Promoter Holding

53.73%

FII Holding

0.38%

DII Holding

Price Chart

Price Performance

1 Week3%

1 Month13%

3 Months57%

6 Months46%

1 Year46%

YTD46%

Moving Average

5 Day SMA2,091

10 Day SMA2,043

20 Day SMA2,018

30 Day SMA1,947

50 Day SMA1,796

61 Day SMA1,721

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	2,285	2,175	2,230	2,294
Resistance 2	2,230	2,167	2,193	2,234
Resistance 1	2,189	2,158	2,171	2,199
Pivot Point	2,135	2,149	2,135	2,139
Support 1	2,094	2,140	2,098	2,103
Support 2	2,040	2,132	2,076	2,044
Support 3	1,999	2,123	2,040	2,008

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%	(0.01) 53.73%
FIIs	(-0.11) 0.38%	(0.01) 0.52%	(0.01) 0.53%	(-0.41) 0.51%	(0.31) 0.87%	(0.01) 0.59%	(0.11) 0.61%	(0.11) 0.52%	(0.01) 0.43%	(0.01) 0.43%	(0.01) 0.42%	(0.01) 0.45%	(0.01) 0.45%	(-0.21) 0.45%	(-0.11) 0.62%	(-0.21) 0.72%	(0.11) 0.92%	(0.11) 0.80%	(0.01) 0.68%
DIIs	(0.01) 0.00%	(0.01) 0.01%	(0.01) 0.00%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.03%	(0.01) 0.03%	(0.01) 0.04%	(0.01) 0.03%	(0.01) 0.02%	(0.01) 0.01%
Public	45.88%	45.75%	45.73%	45.73%	45.38%	45.65%	45.66%	45.74%	45.84%	45.83%	45.84%	45.82%	45.81%	45.77%	45.60%	45.51%	45.31%	45.45%	45.58%
No. of Shareholders	12,373	12,603	12,260	11,810	11,853	11,473	11,538	11,305	12,844	13,450	13,342	12,984	13,120	13,391	13,711	13,439	15,017	16,269	16,399

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	100	77	71	84	82	63	84	82	79	67	70	88	67	74.94	73	51	56.47	56	62.66	60.19
Sales Growth % (YoY)	22.2%	22.5%	-15.2%	2.2%	3.4%	-5.6%	18.8%	-6.4%	17.8%	-10.6%	-3.7%	73.3%	19.2%	34.6%	16.7%	-15.8%	-12%	-2.1%	17.3%	51%
Sales Growth % (QoQ)	29.9%	8.5%	-15.5%	2.4%	30.2%	-25%	2.4%	3.8%	17.9%	-4.3%	-20.5%	31.3%	-10.6%	2.7%	43.1%	-9.7%	0.8%	-10.6%	4.1%	-
Expenses	66	60	59	61	63	58	65	65	63	57	57	73	56	56.18	60	43	46.15	41	45.1	43.12
Operating Profit	34	18	12	23	19	5	19	18	16	10	13	14	12	18.76	13	7	10.32	15	17.56	17.07
OPM %	34	23	17	27	23	8	23	21	20	15	19	16	17	25.03	17	15	18.28	27	28.02	28.36
Other Income	2	2	12	3	-6	9	3	2	5	2	6	3	3	6.37	5	5	7.62	3	1.42	2.35
Interest	5	2	2	2	6	-4	6	5	7	2	8	3	1	3.89	2	2	1.5	1	0.74	0.86
Depreciation	6	4	4	4	4	4	4	4	4	4	4	5	5	5.24	5	5	5.13	5	3.05	3.23
Profit before tax	25	14	17	20	4	13	12	11	10	6	7	9	8	16	10	5	11.31	12	15.19	15.33
Tax %	34	31	16	14	59	15	29	29	35	37	40	25	32	24	36	35	20.34	29	26.73	28.11
Net Profit	17	9	14	17	2	11	8	7	6	4	4	7	6	12.16	7	4	9	8	11.13	11.02
Net Profit Growth % (QoQ)	88.9%	-35.7%	-17.6%	750%	-81.8%	37.5%	14.3%	16.7%	50%	-	-42.9%	16.7%	-50.7%	73.7%	75%	-55.6%	12.5%	-28.1%	1%	-
Net Profit Growth % (YoY)	750%	-18.2%	75%	142.9%	-66.7%	175%	100%	-	-	-67.1%	-42.9%	75%	-33.3%	52%	-37.1%	-63.7%	-	-	-	-
TTM Net Profit	57	42	44	38	28	32	25	21	21	21	29.16	32.16	29.16	32.16	28	32.13	39.15	30.15	22.15	0
EPS in Rs	18.78	10.31	16.99	19.33	1.52	13.71	9.64	7.45	5.82	4.68	4.81	6.9	5.33	13.15	8.16	4.67	9.07	9.97	12.48	14.68

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	333	311	305	266	235	214	183	178	136	123	101	90	69	65
Sales Growth %	6.9%	2.2%	14.4%	13.2%	9.6%	17%	2.9%	31%	10.4%	22.5%	12.1%	30.5%	5.8%	34.8%
Expenses	246	250	251	215	175	146	128	110	89	82	67	64	44	43
Operating Profit	87	62	54	51	60	69	55	68	47	41	34	25	24	22
OPM %	26	20	18	19	26	32	30	38	35	33	34	28	36	34
Other Income	19	8	15	20	14	1	6	7	3	0	1	3	1	0
Interest	11	13	20	9	4	7	7	7	4	4	4	5	6	3
Depreciation	19	17	17	21	17	13	13	12	10	7	6	6	5	4
Profit before tax	76	40	32	40	54	50	41	57	36	31	25	18	13	14
Tax %	24	27	34	30	26	31	25	28	36	26	23	26	31	37
Net Profit	57	29	21	28	39	35	31	41	23	23	19	13	9	9
Net Profit Growth %	96.6%	38.1%	-25%	-28.2%	11.4%	12.9%	-24.4%	78.3%	-	21.1%	46.2%	44.4%	-	-
EPS in Rs	65.41	32.31	22.21	31.3	46.22	40.47	34.29	48.87	30.12	27.68	22.57	15.99	11.11	10.89
Dividend Payout %	17	22	27	26	22	25	19	23	33	19	18	19	18	18

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	64	65	48	24	9	58	37	47	38	35	19	20	9	12
Cash from Investing Activity	-3	-20	-22	-77	-117	-42	-73	-21	-26	-30	-13	-21	-15	-23
Cash from Financing Activity	-49	-52	-26	42	112	-18	19	3	-11	2	-7	7	7	10
Net Cash Flow	12	-7	0	-12	3	-2	-17	28	1	6	-1	5	2	-1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	9	9	9	9	9	9	9	9	9	9	9	9	9	9	9	9
Reserves	352	329	306	293	283	271	251	220	193	169	132	113	93	76	66	59
Borrowings	195	214	213	244	244	274	228	110	121	90	69	66	59	55	48	32
Other Liabilities	123	124	126	123	126	116	74	73	65	32	35	25	25	20	19	24
Total Liabilities	678	675	653	669	662	670	562	411	387	299	244	213	186	160	142	124
Fixed Assets	421	247	233	239	240	259	237	133	142	145	110	102	65	60	54	38
CWIP	0	182	183	171	171	149	82	109	74	7	32	21	36	33	21	29
Investments	43	37	34	32	30	25	21	0	0	0	0	0	0	0	0	0
Other Assets	215	209	203	228	221	237	222	169	170	148	102	89	85	68	68	57
Total Assets	678	675	653	669	662	670	562	411	387	299	244	213	186	160	142	124

Delivery

Delivery Data: HESTERBIO

#	Date	2030 25% 2541	Value (Cr)	Q/T 7	Del 42	Del 1
1	21-Oct	2170	1	6	53	0
2	19-Oct	2267	1	7	34	0
3	16-Oct	2236	1	6	43	0
4	15-Oct	2196	1	6	30	0
5	14-Oct	2158	0	7	38	0
6	13-Oct	2127	0	4	53	0
7	12-Oct	2096	1	8	63	0
8	9-Oct	2059	1	6	35	0
9	8-Oct	2070	1	6	63	0
10	7-Oct	2167	0	5	55	0
11	6-Oct	2174	1	5	40	0
12	5-Oct	2106	1	5	51	0
13	1-Oct	2127	1	4	58	0
14	30-Sep	2176	1	6	61	0
15	29-Sep	2165	1	5	35	0
16	28-Sep	2147	0	5	62	0
17	25-Sep	2183	0	4	44	0
18	24-Sep	2201	0	6	59	0
19	23-Sep	2242	0	4	50	0
20	22-Sep	2179	0	4	67	0
21	21-Sep	2189	1	6	52	0
22	18-Sep	2196	1	7	74	1
23	17-Sep	2246	1	5	42	0
24	16-Sep	2208	1	6	52	1
25	15-Sep	2172	1	5	50	0
26	11-Sep	2265	1	4	45	1
27	10-Sep	2279	1	6	46	0
28	9-Sep	2323	1	5	45	0
29	8-Sep	2318	1	5	50	1
30	7-Sep	2363	2	6	28	1
31	4-Sep	2405	23	11	11	3
32	3-Sep	2202	0	6	44	0
33	2-Sep	2176	2	8	52	1
34	1-Sep	2200	1	7	67	1
35	31-Aug	2259	0	5	62	0
36	28-Aug	2302	1	4	51	0
37	27-Aug	2290	1	6	67	1
38	26-Aug	2354	1	7	52	1
39	25-Aug	2422	1	5	50	0
40	24-Aug	2364	0	5	64	0
41	21-Aug	2368	1	7	69	1
42	20-Aug	2413	0	5	61	0
43	19-Aug	2412	1	6	65	1
44	18-Aug	2451	1	5	38	1
45	17-Aug	2418	1	4	54	0
46	14-Aug	2414	1	5	60	1
47	13-Aug	2461	1	4	54	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	1,851c	89c	4.56
19-Oct	1,940c	37c	1.97
17-Oct	1,902c	0	0
16-Oct	1,902c	26c	1.41
15-Oct	1,876c	13c	0.69
14-Oct	1,863c	42c	2.33
13-Oct	1,821c	54c	3.08
12-Oct	1,766c	16c	0.91
09-Oct	1,750c	2c	0.09
08-Oct	1,748c	71c	3.91
05-Oct	1,820c	16c	0.85
01-Oct	1,835c	5c	0.27
29-Sep	1,830c	10c	0.53
28-Sep	1,821c	53c	2.80
25-Sep	1,873c	17c	0.92
24-Sep	1,891c	35c	1.89
22-Sep	1,855c	41c	2.16
17-Sep	1,896c	74c	3.73
10-Sep	1,970c	29c	1.44
07-Sep	1,999c	0	0

Stock Checklist

Price is above from 52 week high low average: 65%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Oct26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.05%	-0.01%	0

Hester Biosciences Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements